Aviva Holdings Ltd. - Q3 2020 holdings

$767 Million is the total value of Aviva Holdings Ltd.'s 4 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 40.0% .

 Value Shares↓ Weighting
MRTX  MIRATI THERAPEUTICS INC$520,727,000
+45.4%
3,135,9660.0%67.85%
+21.8%
INSG  INSEEGO CORP$226,684,000
-11.0%
21,965,5040.0%29.54%
-25.5%
 INSEEGO CORPnote 3.250% 5/0$20,015,000
-11.0%
24,456,0000.0%2.61%
-25.5%
SLDB ExitSOLID BIOSCIENCES INC.$0-11,488
-100.0%
-0.01%
PAM ExitPAMPA ENERGIA S Aspons adr lvl i$0-697,603
-100.0%
-1.14%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Braslyn Ltd. #1
  • Golden Harbor Ltd. #2
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2020-11-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MIRATI THERAPEUTICS INC32Q3 2023100.0%
INSEEGO CORP21Q3 202339.6%
INSEEGO CORP14Q3 202310.2%
PAMPA ENERGIA SA ADR12Q3 202226.0%
MEDICINES CO11Q3 201987.4%
ESPERION THERAPEUTICS INC NE9Q1 201914.2%
TANGO THERAPEUTICS INC.9Q3 20230.2%
SOLID BIOSCIENCES INC.9Q2 20200.1%
INSEEGO CORP8Q1 202041.4%
MACROGENICS INC.6Q4 201810.0%

View Aviva Holdings Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Aviva Holdings Ltd.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Aviva Holdings Ltd.'s holdings